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Introduction
Efficient renal drug elimination involves active secretion in proximal tubules. Thereby, transporters in the basolateral and luminal (brush-border) membrane co-operate in taking up a drug from blood and delivering it to the primary urine. For anionic, i.e. negatively charged, compounds, the organic anion transporters 1 (OAT1; SLC22A6) and OAT3 (SLC22A8) are the main uptake transporters, functioning physiologically as organic anion/-ketoglutarate exchangers (reviewed in VanWert et al., 2010 , Pelis and Wright, 2011 , Burckhardt, 2012 , Morrissey et al., 2013 , Nigam et al., 2015 , whereas the ATP-driven multidrug resistance-associated proteins MRP2 (ABCC2) and MRP4 (ABCC4) accomplish efflux into the tubule lumen (Masereeuw and Russel, 2010) .
Co-operation in trans-cellular drug secretion requires that OATs and MRPs exhibit overlapping specifities for their substrates.
In an ongoing search for specific inhibitors of MRP4 that confers resistance of tumor cells to a variety of antineoplastic agents (for review : Keppler, 2011 , Russel et al, 2008 , Wen et al., 2015 , the FDA-approved drugs dantrolene, glafenine, nalidixic acid, and prazosin were identified, being even more selective inhibitors than the commonly used leukotriene 4 receptor antagonist, MK-571 (Cheung et al., 2015) .
Dantrolene, glafenine, nalidixic acid, and prazosin are structurally unrelated and are, at physiological pH, mainly uncharged (glafenine, prazosin), zwitterionic (dantrolene) or negatively charged (nalidixic acid), respectively (Table 1 ). In addition, these drugs serve various therapeutic purposes. Dantrolene is the only available drug to treat malignant hyperthermia (Krause et al., 2004 , Rosenberg et al., 2015 . Glafenine is a nonsteroidal anti-inflammatory agent that has meanwhile been taken from the market (Withdrawal of glafenine 
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translocation, the test compound must be available in radio-or fluorescence-labeled form or detectable by mass spectroscopy. Indirect evidence of translocation is provided by trans-stimulation experiments in which the labeled substrate is usually offered from the outside, and the test agent from the inside of the cell, respectively.
However, this type of experiment relies on the efficient uptake of test compounds before the addition of the labeled reference substrate. Whether this prior uptake took place is not known in many cases.
Since dantrolene, glafenine, nalidixic acid, and prazosin are not available in radio-labeled form, we employed a technique previously called competitive counter flow (Harper and Wright, 2013) . In this setting, cells are equilibrated with their radio-labeled reference substrate. Thereafter, a test compound is added to the medium in the continuous presence of the labeled reference substrate. If the test compound enters the cell via the transporter under investigation, it will force the efflux of radio-labeled reference substrate by exchange (antiport). Thereby, the equilibrium distribution of the reference substrate is distorted, leading to a decrease in its intracellular content. The energy for this downward shift of equilibrium is provided by flux coupling of drug influx driving substrate efflux. Since OAT1 and OAT3 physiologically operate as antiporters, this technique appeared applicable to indirectly test for translocation of dantrolene, glafenine, nalidixic acid, and prazosin by these transporters.
It turned out that all four drugs cis-inhibited OAT3-driven estrone-3-sulfate (ES) uptake and downward shifted the ES equilibrium. With OAT1, dantrolene, glafenine, and prazosin cis-stimulated p-aminohippurate (PAH) uptake but cis-inhibited glutarate uptake, suggesting a complex interaction with this transporter. The anionic nalidixic acid cis-inhibited PAH as well as glutarate uptake. A downward shift in equilibrium was observed only with nalidixic acid, suggesting its exchange with intracellular PAH or glutarate through OAT1.
This article has not been copyedited and formatted. The final version may differ from this version. Bradford (Bradford, 1976 Figure 6B ). In pcDNA5-transfected HEK293 cells, the 2 min PAH content was significantly higher in the presence of the drugs than in their absence ( Figure 6B , black bars). Calculation of the 2 min OAT1-dependent [ 3 H]PAH content, i.e. uptake into OAT1-minus uptake into pcDNA5-transfected cells, revealed a significant decrease by nalidixic acid, but not by dantrolene, glafenine, and prazosin ( Figure 6C ).
This article has not been copyedited and formatted. The final version may differ from this version. , Pelis and Wright, 2011 , Burckhardt, 2012 , Morrissey et al., 2013 , Nigam et al., 2015 . These OATs take up organic anions from the blood in exchange against intracellular -ketoglutarate. Since a high intracellular -ketoglutarate concentration is maintained by metabolism and by sodium-driven uptake across luminal and basolateral membranes (Dantzler, 2002) , organic anion transport across the basolateral membrane is continuously poised into the uptake direction. Multidrug resistance-associated protein 4 (MRP4; gene name ABCC4) is an ATP-driven export pump that is, among other transporters, involved in the release of organic anions into the primary urine (reviewed in Keppler, 2011 , Russel et al., 2008 , Wen et al., 2015 . ATP hydrolysis provides the driving force for organic anion efflux across the luminal membrane.
When OAT1/3 in the basolateral membrane and MRP4 in the luminal membrane are to co-operate efficiently in proximal tubular anion secretion, it is mandatory that their spectrum of transported substrates overlaps broadly. Hence, we reasoned that the recently detected MRP4 inhibitors dantrolene, glafenine, nalidixic acid, and prazosin (Cheung et al., 2015) 12.9% of dantrolene is net negatively charged, and 96.6% of nalidixic acid is present in the anionic form; yet dantrolene was a more potent inhibitor than nalidixic acid. Prazosin and nalidixic acid were equipotent inhibitors despite the fact that prazosin is partially cationic (41.1%) and nalidixic acid is nearly completely anionic. The previously described interaction of OAT3 with the cationic H2 receptor antagonist, cimetidine, is in line with the assumption that this transporter is able to interact with organic anions, zwitterions, and cations (Tahara et al., 2005) . In equilibrium shift assays, un-labeled ES was most and prazosin was least effective in decreasing the activity. Prazosin had no effect. The rank order of inhibition is distint from that on OAT3 (see above) and the IC50 values tended to be higher (see Table 2 (Smeets et al., 2004) that is endogenously expressed in HEK cells (Cheung et al., 2015 , Henjakovic et al., 2015 , this may not be the case for glutarate for which an efflux transporter is not known. Table 2 
